2021
DOI: 10.1101/2021.01.25.428175
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Can we put Humpty Dumpty back together again? What does protein quantification mean in bottom-up proteomics?

Abstract: Bottom-up proteomics provides peptide measurements and has been invaluable for moving proteomics into large-scale analyses. In bottom-up proteomics, protein parsimony and protein inference derived from these measured peptides are important for determining which protein coding genes are present. However, given the complexity of RNA splicing processes, and how proteins can be modified post-translationally, it is overly simplistic to assume that all peptides that map to a singular protein coding gene will demonst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 36 publications
1
3
0
Order By: Relevance
“…Imputation of missing data values and peptide grouping did not significantly alter the CV. As highlighted previously 69 , protein grouping further improved the median CV to 20.89%…”
Section: Resultssupporting
confidence: 62%
See 1 more Smart Citation
“…Imputation of missing data values and peptide grouping did not significantly alter the CV. As highlighted previously 69 , protein grouping further improved the median CV to 20.89%…”
Section: Resultssupporting
confidence: 62%
“…Imputation of missing data values and peptide grouping did not significantly alter the CV. As highlighted previously 69 , protein grouping further improved the median CV to 20.89% To assess whether individual protein quantities measured by Mag-Net could distinguish between disease states we used a combination of receiver operator characteristic (ROC) curve analysis and machine learning. We performed six pairwise analyses including 1) ADD versus all others, 2) HCN versus all others, 3) PDD versus all others, 4) PDCN versus all others, 5) dementia (ADD and PDD) versus cognitively normal (HCN and PDCN), and 6) Parkinson's disease (PDCN and PDD) versus non-Parkinson's disease (ADD and HCN).…”
Section: Use Of Plasma Evs To Assess Molecular Markers For Alzheimer'...mentioning
confidence: 99%
“…The investigation of bipartite peptide-protein graphs is therefore highly relevant to the current research in proteomics. Furthermore, the analysis pf bipartite graphs can also be applied to the field of proteoform research by including isoforms and and peptides with PTMs [49].…”
Section: Discussionmentioning
confidence: 99%
“…While such data is increasingly deposited into searchable public data repositories such as ProteomicsDB ( 5 ), PRIDE ( 6 ), MassIVE ( http://massive.ucsd.edu ), or PeptideAtlas ( 7 ), estimating the proportion of false positive identifications (false discovery rate; FDR) at the gene-level is a nontrivial task ( 8 , 9 , 10 ). An even larger challenge is presented by distinguishing between different protein products from the same gene ( 11 ), such as splice variants ( 12 ) or SNPs or when analyzing mixtures of orthologous proteins from different species such as human/mouse xenografts or bacterial communities in metaproteomics ( 13 ).…”
mentioning
confidence: 99%